Tom Lin is the founder of Belite Bio. Belite Bio has raised $92M in total funding. Latest round: IPO. Based in San Diego, California, USA.
Tom Lin is the Founder, Chairman, and Chief Executive Officer of Belite Bio, a drugmaker that focuses on treatments for Stargardt disease and dry age-related macular degeneration. Belite Bio emerged as one of biotech's best-performing IPOs, with shares up nearly 500% since its debut. Lin is also the Founder of Lin BioScience, Inc., which is Belite Bio's ultimate controlling shareholder.
Full founder directory · Investor directory · Company funding database · Fundraising library